The increasing need for process optimization, regulatory compliance, and supply chain improvements are driving investments in automation technologies across the pharmaceutical industry. Concurrently, the existing automation systems are going through a continuous evolution of instruments and control products. Find below the latest advancements in the pharmaceutical space:
The adoption of single-use bioreactors and other unit operations among the single-use technologies is reshaping the way automation is delivered. Additionally, the integration of manufacturing execution system (MES) and process control systems with the single-use manufacturing platforms are aiding the industry to deploy biopharmaceutical manufacturing with increased productivity and efficiency. The lower cost association has also significantly reduced the time-to-market for new products.
Multi-Product Manufacturing Facilities
The days of developing the same product year after year are over. The manufacturing industry is experiencing a transition away from “one-line-one-product” setups to multi-product manufacturing facilities. Such sites are designed with the capability to react to changing demands quickly. Alongside, the growing trend toward contract manufacturing is also driving the need for more flexible facilities to meet the needs of multiple customers.
The industry 4.0 has become extremely important to the continued success and competitiveness of pharmaceutical manufacturers. Intelligent factories, integrated IT systems, the Internet of Things (IoT), and highly integrated manufacturing systems have formed the core smart, decentralized production. The life science manufacturing industry believes in using proven solutions and approaches to improve quality, reliability, and reduce waste. The industry has been collecting and using evidentiary data to improve their manufacturing processes and have some of the best quality systems in the world.